Latest filing published 03 Jul 2014 for Idera Pharmaceuticals, INC., €1,369.
Insider track record
No signal scores available.
Malcolm MacCoss: trading record in brief
Malcolm MacCoss discloses dealings in Idera Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 1 October 2010 to 1 July 2014, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 3 July 2014, the filings show a share grant worth €1,369 in Idera Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Malcolm MacCoss
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 662 shares@ US$2.83Common StockSEC:0001209191-14-045985:0
- 1,216 shares@ US$1.17Common StockSEC:0001209191-12-036276:0
- 1,875 shares@ US$3.30Common StockSEC:0001209191-10-048676:0
3 of 3 declarations